Spain – Various medicinal products – ACUERDO MARCO DEL SUMINISTRO DE LOS MEDICAMENTOS ADALIMUMAB Y GOLIMUMAB

awarded

Consorci de Salut i d'Atenció Social de Catalunya · 8885209

Read the notice at ted-eu ↗

Value

€38m

Published

2 Nov 2026

Deadline

—

Type

award · framework

33690000 · Medical equipment, pharmaceuticals & personal care

Description

Acuerdo Marco del Suministro de los Medicamentos ADALIMUMAB Y GOLIMUMAB

Key facts

Procedure: open
Framework agreement: Yes — a framework or dynamic purchasing system, not a single contract
Contact: sacac@consorci.org
Regime: publicSector
Contract references: CSC F 26/08 - 0
Category: supplies

Awarded suppliers

AMGEN SA · A59363655 · ES511, ES
ABBVIE SPAIN, S.L.U · B86418787 · ES300, ES
BIOGEN SPAIN S.L. · B83086736 · ES300, ES
BIOCON BIOLOGICS SPAIN, S.L · B13684279 · ES511, ES
Sandoz farmacéutica S.A · A08233801 · ES300, ES
JANSSEN-CILAG, S.A. · A28925899 · ES300, ES
KERN PHARMA, S.L. · B58296773 · ES511, ES
ADVANZ PHARMA SPAIN, S.L. · B86181716 · ES300, ES
FRESENIUS KABI ESPAÑA, S.A. · A08130502 · ES511, ES

What a subscription adds to this notice

The documents — every attachment, with its text extracted and searchable
Qualification — the notice scored against your company profile
Tracking and alerts — a pipeline for your bids, and the matching notices by email
The API and MCP — the same record in your own tools and your AI assistant

Start your 7-day free trial Sign in

Provenance

Source: ted-eu
Notice id: 758525-2026
First seen: 2 Nov 2026
Last updated: 2 Nov 2026

Licence EU reuse — Commission Decision 2011/833/EU ↗

Source: TED — Tenders Electronic Daily (ted.europa.eu), © European Union, reused under Commission Decision 2011/833/EU.

View at source ↗GET /api/v1/tenders/77e8e812-112c-4144-8d74-09c7305d0803

The source notice is authoritative — verify deadlines and documents there before bidding.